- Favorable safety profile of ixekizumab: results from 11 moderate-to-s…
Number of the records: 1  

Favorable safety profile of ixekizumab: results from 11 moderate-to-severe psoriasis and 3 psoriatic arthritis clinical trials

  1. Favorable safety profile of ixekizumab: results from 11 moderate-to-severe psoriasis and 3 psoriatic arthritis clinical trials / Alice Gottlieb ... [et al.].
    In: XIV. kongres slovenských a českých dermatovenerológov s medzinárodnou účasťou. -- S. 19-20. -- [S.l. : s.n., 2018].
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.